Active, not recruitingPhase 2NCT04262141

IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)

Studying Essential thrombocythemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Terrence J Bradley, MD
Principal Investigator
Terrence J Bradley, MD
University of Miami
Intervention
IMG-7289(drug)
Enrollment
4 enrolled
Eligibility
18 years · All sexes
Timeline
2020 – 2027

Study locations (1)

Collaborators

Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04262141 on ClinicalTrials.gov

Other trials for Essential thrombocythemia

Additional recruiting or active studies for the same condition.

See all trials for Essential thrombocythemia →

← Back to all trials